US-based pharmaceutical firm Egalet has entered into a definitive collaboration and license agreement with Japan-based Shionogi for the development and commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates ...
Tags: Egalet, Product Candidates
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
US-based pharmaceutical firm Zogenix has entered into a development and option agreement (D&O Agreement) with Altus Formulation (Altus) to develop abuse deterrent formulations of Zohydro ER (hydrocodone bitartrate) extended-release ...
Tags: Zogenix, Zohydro ER
Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic diseases. The deal will see the ...
Tags: injectable drug, Innocore
US-based Mystic Pharmaceuticals has secured two Notices of Allowance from the US Patent Office for its Unit Dose Drug Delivery Platform and Piercing Device for Drug Delivery Systems patent applications. According to the company, the new ...
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
Israel-based innovative drug carriers developer PolyPid has signed a strategic partnership agreement with MIS Implants Technologies, a US- based dental implants manufacturer, to provide a new drug delivery product for dental applications. ...
Tags: MIS, drug delivery product, innovative drug
Rainbow BioSciences' biotech division Rainbow Coral (RBCC) has revealed that it is currently working on a potential joint venture agreement with a privately held drug delivery company to develop and market a sustained-release drug delivery ...
Tags: RBCC, Sustained-Release Drug, Medicine
TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide variety of therapeutic applications, today announced that its patented extrusion technology enables absorbable fibers ...
Tags: cutting-edge absorbable polymer technology, implantable drug delivery
ScinoPharm and Foresee Pharmaceuticals have signed an agreement to form a joint venture for developing a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug used for treating prostate cancer. ...
NanoSmart Pharmaceuticals and University of California Los Angeles (UCLA) have signed a research alliance to advance the development of the drug delivery platform that uses human autoimmune antibodies targeting several tumor types. ...
Halozyme Therapeutics has entered into collaboration and license agreement with Pfizer for the development and commercialization of subcutaneous biologics. The collaboration will focus on developing Pfizer biologics, leveraging Halozyme's ...
Tags: biologics, Halozyme Therapeutics, subcutaneous biologics, treatments
Atlantic Pharmaceuticals has received two new US Patent and Trademark Office (USPTO) patents for its tamper-resistant SMART/Script drug delivery platform. The patents cover company's tamper-resistant platforms, designed to resist dose ...
Tags: Atlantic Pharmaceuticals, US Patent, drug delivery platform, healthcare
InSite Vision has launched a new DuraSite 2 drug delivery system, designed to deliver ophthalmic therapeutics. DuraSite 2, which is based on InSite DuraSite technology, incorporates cataract surgery drug, ketorolac, a non-steroidal ...
Tags: InSite, Ophthalmic Drug Delivery System, ophthalmic therapeutics
MedPro Safety Products has signed a letter of intent with a specialty pharmaceutical company for licensing its drug delivery platform, designed for safer medication delivery and blood collection. On the terms of a definitive ...
Tags: drug delivery platform, MedPro, pharmaceutical products